Medical Products Company
Covidien has acquired 22 companies of its own. A total of 4 acquisitions came from private equity firms. It has also divested 4 assets.
Covidien’s largest acquisition to date was in 2010, when it acquired ev3 for $2.6B. It’s largest disclosed sale occurred in 2013, when it sold Confluent Surgical to Integra LifeSciences Holdings for $265M. Covidien has acquired in 6 different US states, and 3 countries. The Company’s most targeted sectors include medical products (72%) and healthcare services (24%).
Join Mergr and gain access to Covidien’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the medical products sector.
M&A Summary
-
M&A Total Activity25
- M&A Buy Activity21
- M&A Sell Activity4
- Total Sectors Invested 3
- Total Countries Invested 3
- M&A Buy/Sell Connections 9
- M&A Advisors 1
Unlimited Searches
